Oscar Health, Inc. (NYSE:OSCR) Shares Bought by Algert Global LLC

Algert Global LLC grew its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 63.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 369,685 shares of the company’s stock after acquiring an additional 143,346 shares during the quarter. Algert Global LLC owned about 0.15% of Oscar Health worth $7,841,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Kingsview Wealth Management LLC bought a new stake in shares of Oscar Health during the third quarter valued at about $446,000. Charles Schwab Investment Management Inc. raised its stake in shares of Oscar Health by 20.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock valued at $33,940,000 after purchasing an additional 270,223 shares in the last quarter. Intech Investment Management LLC bought a new stake in shares of Oscar Health during the third quarter valued at about $1,282,000. Swiss National Bank raised its stake in shares of Oscar Health by 17.8% during the third quarter. Swiss National Bank now owns 314,900 shares of the company’s stock valued at $6,679,000 after purchasing an additional 47,500 shares in the last quarter. Finally, KBC Group NV raised its stake in shares of Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after purchasing an additional 1,328 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on OSCR shares. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Piper Sandler reiterated an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target on the stock. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $22.93.

Insider Activity

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total value of $426,250.00. Following the completion of the sale, the director now directly owns 89,512 shares of the company’s stock, valued at $1,526,179.60. This represents a 21.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Victoria Baltrus sold 4,226 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the transaction, the chief accounting officer now directly owns 140,648 shares in the company, valued at $2,530,257.52. The trade was a 2.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 194,569 shares worth $3,433,319. Corporate insiders own 25.11% of the company’s stock.

Oscar Health Trading Down 2.0 %

Shares of OSCR opened at $15.98 on Friday. The business’s 50-day moving average price is $17.90 and its 200 day moving average price is $18.20. The stock has a market capitalization of $3.95 billion, a P/E ratio of -266.33 and a beta of 1.67. Oscar Health, Inc. has a 1-year low of $7.29 and a 1-year high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. During the same period in the prior year, the business posted ($0.29) EPS. The company’s revenue for the quarter was up 68.3% compared to the same quarter last year. Analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.